Compare ARK Genomic Revolution ETF (ARKG) vs iShares Silver Trust (SLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares Silver Trust — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while iShares Silver Trust trades at $52.87. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares Silver Trust nearer its low. Which is the better fit depends on your goals.
| ARKG | SLV | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $105.57 |
52-Week Low | $23.09 | $33.32 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
SLV (iShares Silver Trust) trades at $53.95, down 0.35% on the day, with a bearish technical signal from moving averages while oscillators remain neutral. Recent news highlights silver's industrial metal outperformance versus gold in 2026, with StoneX forecasting silver prices between $55-60 per ounce for year-end. The ETF provides direct exposure to physical silver bullion with a 0.50% expense ratio.
Silver's dual role as both precious and industrial metal creates unique investment dynamics, with current sentiment balanced between geopolitical tensions and Federal Reserve policy uncertainty. Key risks include silver price volatility and interest rate sensitivity, while potential catalysts include continued industrial demand and precious metals rotation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares Silver Trust
The ETF seeks to reflect such performance before payment of the ETF's expenses and liabilities. It is not actively managed. The ETF does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of silver.
Read more on SLV →
